Enhancing and improving CAR-T cell therapy: an interview with Bruce Levine

25 Apr 2019

For clinicians Industry and business Opinion

Photo credit: Rita Elena Serda In this interview with Bruce Levine Ph.D. (University of Pennsylvania, PA, USA) we find out about his talk on constantly enhancing and improving engineered T cells, which was presented recently at the American Association for Cancer Research (AACR) Annual Meeting (March 29–April 3, 2019, Atlanta, GA, USA). In addition, we also asked about his thoughts on two CAR-T studies that caught the news headlines at AACR 2019. Could you give us an overview of your talk at AACR on enhancing and improving engineered T cells?I started by describing CAR-T cells as a different type of drug...